Curt Bradshaw - Net Worth and Insider Trading
Curt Bradshaw Net Worth
The estimated net worth of Curt Bradshaw is at least $0 dollars as of 2024-11-13. Curt Bradshaw is the Chief Scientific Officer of Arrowhead Pharmaceuticals Inc and owns about 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $0. Details can be seen in Curt Bradshaw's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Curt Bradshaw has not made any transactions after 2020-11-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Curt Bradshaw
Curt Bradshaw Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Curt Bradshaw owns 2 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) , and NeuBase Therapeutics Inc (NBSE) .
Click here to see the complete history of Curt Bradshaw’s form 4 insider trades.
Insider Ownership Summary of Curt Bradshaw
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2020-11-20 | Chief Scientific Officer |
NBSE | NeuBase Therapeutics Inc | 2020-12-01 | Chief Scientific Officer |
Curt Bradshaw Latest Holdings Summary
Curt Bradshaw currently owns a total of 1 stock. Curt Bradshaw owns 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of November 20, 2020, with a value of $0.
Latest Holdings of Curt Bradshaw
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARWR | Arrowhead Pharmaceuticals Inc | 2020-11-20 | 0 | 21.51 | 0 |
Holding Weightings of Curt Bradshaw
Curt Bradshaw Form 4 Trading Tracker
According to the SEC Form 4 filings, Curt Bradshaw has made a total of 1 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 31,250 shares on November 20, 2020, which brought Curt Bradshaw around $2 Million.
Insider Trading History of Curt Bradshaw
- 1
Curt Bradshaw Trading Performance
Curt Bradshaw Ownership Network
Ownership Network List of Curt Bradshaw
Ownership Network Relation of Curt Bradshaw
Curt Bradshaw Owned Company Details
What does Arrowhead Pharmaceuticals Inc do?
Who are the key executives at Arrowhead Pharmaceuticals Inc?
Curt Bradshaw is the Chief Scientific Officer of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include Chief Commercial Officer Tracie Oliver , other: Senior Vice President James C Hamilton , and CFO Kenneth Allen Myszkowski .
Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary
Over the past 18 months, Curt Bradshaw made no insider transaction in Arrowhead Pharmaceuticals Inc (ARWR). Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 161,544 shares made by Christopher Richard Anzalone , a net sale of 55,383 shares made by James C Hamilton , and a net sale of 71,104 shares made by Kenneth Allen Myszkowski .
In summary, during the past 3 months, insiders sold 0 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 385,678 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 382,678 shares.
Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arrowhead Pharmaceuticals Inc Insider Transactions
Curt Bradshaw Mailing Address
Above is the net worth, insider trading, and ownership report for Curt Bradshaw. You might contact Curt Bradshaw via mailing address: 177 E Colorado Blvd, Ste 700, Pasadena Ca 91105.